The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study - Wikidata - wikimedia - TriplyDB

The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study

The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study

http://www.wikidata.org/entity/Q36477727

about

The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary disease Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model Deciphering Modern Glucocorticoid Cross-pharmacology Using Ancestral Corticosteroid Receptors The cardiac protein αT-catenin contributes to chemical-induced asthma Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism.Crosstalk between beta-2-adrenoceptor and muscarinic acetylcholine receptors in the airway Role for β-arrestin in mediating paradoxical β2AR and PAR2 signaling in asthma.Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.For the love of paradox: from neurobiology to pharmacology Biochemical basis of asthma therapy.Epinephrine Activation of the β2-Adrenoceptor Is Required for IL-13-Induced Mucin Production in Human Bronchial Epithelial Cells.Long-Acting Beta Agonists Enhance Allergic Airway Disease Effects of hydrocortisone on acute β-adrenoceptor blocker and histamine induced bronchoconstriction.β-Blockers have differential effects on the murine asthma phenotype.Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study.Therapeutic options for severe asthma Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model.Assessment of murine lung mechanics outcome measures: alignment with those made in asthmatics.β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model.Differences in asthma study models and the effectiveness of β2 -adrenoceptor ligands: response to Lipworth et al.Beta-blockers: friend or foe in asthma?Management of asthma in the elderly patient.Agonizing over agonism: should asthmatics turn their beta-receptors on or off?Similarities and differences in the autonomic control of airway and urinary bladder smooth muscle A meta-analysis of the effects of β-adrenergic blockers in chronic heart failure Advances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway disease.β2-adrenoreceptor Inverse Agonist Down-regulates Muscarine Cholinergic Subtype-3 Receptor and Its Downstream Signal Pathways in Airway Smooth Muscle Cells in vitro.Current concepts on the use of glucocorticosteroids and beta-2-adrenoreceptor agonists to treat childhood asthma beta-Adrenoceptor inverse agonists in asthma New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.Initial experience using propranolol as an adjunctive treatment in children with aggressive recurrent respiratory papillomatosis.β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectives.GPCRs and arrestins in airways: implications for asthma.Ligand bias prevents class equality among beta-blockers.Noradrenaline transmission reducing drugs may protect against a broad range of diseases.Effects of β-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype.β2 Agonists Cardiomyocytes of the Heart and Pulmonary Veins: Novel Contributors to Asthma?Beta-Adrenergic Agonists

P2860

Q22305858-DE841252-2FAA-477B-A0EC-FDA5D12743AF Q24646260-536B2B94-6847-4DDD-8E3F-016B592E81A3 Q27678139-75500CDD-7AB3-43A7-99CF-C7C0871B890D Q28388603-34322D14-027A-4832-A21D-1394947D812F Q33792699-A8FEBF65-4D5B-4CA9-9569-85C063A17C81 Q33896990-E42B6370-9638-4AED-9CCE-5813A3353F64 Q33975010-7D16A3B4-1825-4CD2-874A-8411B818F088 Q34575920-3BF4063F-F542-421D-991D-DC19EA07CE64 Q34837191-FD1D2234-4ECE-4114-B20A-A1693D591274 Q35163044-FE6F5AB0-BCA8-4F4B-A67B-777AF881BA5C Q35312155-0BC272BD-C813-4266-B988-6D410D47B020 Q35688187-629D7062-7FD1-48C3-8106-77F628488313 Q35852118-65C9C223-D4DD-4B10-9B32-D55827EB52C1 Q36111202-1663541F-C6EE-4A04-B73B-709E816F14F0 Q36211207-5900AE10-CEFB-44D6-A0B5-0948354ED0F0 Q36261786-8FDB777E-1816-4030-97B1-8B23FC8FDAF2 Q36286252-8965AF70-3BCE-48AF-B432-98A8B2385C87 Q36482653-DFE14F93-3048-402E-908F-5884663B008C Q36602201-C07F3B51-570C-492B-84E4-DD2532AF70CE Q36703892-EF48A9B6-2EE9-40FF-882E-A49639DB584A Q36744208-5191ED1B-C384-4446-91B2-48BC8DBF1F0F Q37006857-8C76B7B8-613E-43BF-B1E8-D73C07973BA0 Q37027409-5C427829-AD06-4393-A513-F0D8731BD97F Q37114730-9DB5F598-CED0-486D-BB69-080F75E96F5E Q37189382-B940189D-51A6-427A-8FD1-F317075BA7FA Q37289514-D19D6FBE-7C78-4851-8F35-144CCDD96238 Q37516982-2DCFB63A-B474-40BD-8DDD-938CADF24A22 Q37554447-8DA6D309-24F0-43ED-8FEF-49C9A0AFB902 Q37694255-AD6C3F93-13F9-47C2-9759-C12DC0D64AD2 Q37732847-68D32714-F2B7-4397-8AF3-C24BC851D03F Q37822833-FBD3240A-5EE6-40F5-8D22-09FBA4797FB9 Q37849276-1BF7D397-355C-4AA0-9720-B4C5289F1091 Q38152743-2C773E96-8003-4CF1-911D-777F018191A3 Q38167643-C979F00F-2360-420A-87CC-378925278368 Q38200427-A8443EF1-28AA-4F14-B93E-0E9889B6CB43 Q38255794-3C99D510-5CF7-44C2-8204-7A48011C094F Q38669392-C01B4340-C793-4EA8-B9A8-0D1567038BF6 Q38791742-3186682E-61E6-4073-92B0-1B44D0B922F5 Q38798374-45259EA8-81E9-4626-82A5-576FAB3E11EA Q38974241-448B3345-F6A2-4FF6-833F-BE60FD574E46

P2860

The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study

http://www.wikidata.org/entity/Q36477727

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

The safety and effects of the ...... hma: an open-label pilot study

@ast

The safety and effects of the ...... hma: an open-label pilot study

@en

type

label

The safety and effects of the ...... hma: an open-label pilot study

@ast

The safety and effects of the ...... hma: an open-label pilot study

@en

prefLabel

The safety and effects of the ...... hma: an open-label pilot study

@ast

The safety and effects of the ...... hma: an open-label pilot study

@en

P1433

Q36477727-EB5D4834-A347-40C7-A52F-2B8DAB3B2320

P1476

Q36477727-3A9A0FCF-5EEB-4E70-909E-24B492ADAEDD

P2093

Q36477727-0070F14B-F82E-4F9E-ABE6-90F457DD33A8

Q36477727-1166B8A3-C8C4-457F-97ED-5A8039391B97

Q36477727-181344D1-2149-40DB-8736-B8E1EE019165

Q36477727-282AADAB-C235-4ADC-8B1E-8C65535FF8AA

Q36477727-6E1CB1DF-947A-471D-AA98-00FFA3893F2C

Q36477727-75241A18-D9C5-4B3D-AD45-B0D78204B14B

Q36477727-AA1CF61A-4145-4F1B-9CE5-AED214D005CB

Q36477727-D1BFE1D6-5BF8-4EBF-A254-C0AED031236A

Q36477727-F0C31305-BA55-4421-8FED-6BDBB5FA4868

P2860

Q36477727-027FA9E5-E534-4589-BEA6-E7E455B1A43B

Q36477727-03AC7D28-C4AB-4EED-A2D7-2C75DAB77A84

Q36477727-055A6C8E-1F46-477E-B1A6-EDA16BE54616

Q36477727-15A8FAF1-7DA7-4DF6-A0BF-BF3FCA04ED6F

Q36477727-1D8FE550-C567-4BCA-A146-8084EC373CAF

Q36477727-213E3AC5-08F6-49F7-8594-D838DF883FAF

Q36477727-2AC4C9A0-0393-4DBB-81E4-E22BD460BC09

Q36477727-3E76C26D-85EB-43CD-9EE3-85BEC37BDB8E

Q36477727-4B13C16D-5B5D-45A6-B5E4-BFF60638369B

Q36477727-4FCB9770-593E-4642-B2A9-A90BB98DA884

P304

Q36477727-DFE44C67-7F45-4858-BEFF-4D772D8CE1E3

P31

Q36477727-1A8F2EA0-D4AF-4D86-A477-0C265E10580C

P356

Q36477727-4C5D0641-2F1B-4E6F-8873-6194F914B2EF

P433

Q36477727-EAFF8D4E-9BF3-4C7A-85F4-54C0FDB6EFA0

P478

Q36477727-5498C2B9-926D-4199-B885-24FFED521AD4

P50

Q36477727-1864646E-F746-47F0-AA3E-55EA154E61CD

Q36477727-27D94AD0-18CA-4E6E-9E9E-081F3D04239E

Q36477727-64CFB286-B49A-4A66-8D12-9E0622F4D3A6

Q36477727-80C2F250-C675-40C8-BE15-7339BDFEB4EB

P577

Q36477727-5F23C8BD-DE02-4010-B850-016C1C3B79CC

P5875

Q36477727-2B6612B5-3D50-4182-A854-F1E42CCBA687

P698

Q36477727-7A3C3F99-F57D-477A-93B2-9892F8A04B22

P921

Q36477727-6BC4926E-DDCF-4B19-9204-9F6B3A80827D

P932

Q36477727-AF0B037D-D3F9-46EA-92B9-47F71EA1C17B

P356

J.PUPT.2007.07.002

P1433

Pulmonary Pharmacology & Therapeutics

P1476

The safety and effects of the ...... hma: an open-label pilot study

@en

P2093

Amie E Franklin

http://www.w3.org/2001/XMLSchema#string

Brian J O'Connor

http://www.w3.org/2001/XMLSchema#string

Felix Shardonofsky

http://www.w3.org/2001/XMLSchema#string

Michael Flashner

http://www.w3.org/2001/XMLSchema#string

Rami El-Wali

http://www.w3.org/2001/XMLSchema#string

Richard A Bond

http://www.w3.org/2001/XMLSchema#string

Stephen Ruoss

http://www.w3.org/2001/XMLSchema#string

Supria Singh

http://www.w3.org/2001/XMLSchema#string

William J Garner

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths

Antithetic regulation by beta-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway beta-agonist paradox

Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.

Is paradoxical pharmacology a strategy worth pursuing?

Can intellectualism stifle scientific discovery?

Adverse effects of beta-agonists.

Serious asthma exacerbations in asthmatics treated with high-dose formoterol.

Beta-agonists and asthma: too much of a good thing?

P304

134-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PUPT.2007.07.002

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Burton F Dickey

Nicola A Hanania

P577

2007-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6135765

http://www.w3.org/2001/XMLSchema#string

P698

17703976

http://www.w3.org/2001/XMLSchema#string

P921

P932

2254137

http://www.w3.org/2001/XMLSchema#string